Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer
Clinical trial NCT05372692 · COMPLETED
Trial details
- NCT number
- NCT05372692
- Sponsor
- Weijia Fang, MD
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-12
- Primary completion
- 2023-02-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.